Synairgen's SNG001 shows strong promise in COVID-19 trial

20th July 2020 Uncategorised 0

The drug significantly cut the risk of developing severe disease and patients were twice as likely to recover versus placebo

More: Synairgen's SNG001 shows strong promise in COVID-19 trial
Source: News